Screener
Bausch Health Companies BHC Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| (in millions) | March 31, 2026 / Gross Carrying Amount | March 31, 2026 / Accumulated Amortizationand Impairments | March 31, 2026 / Net Carrying Amount | December 31, 2025 / Gross Carrying Amount | December 31, 2025 / Accumulated Amortizationand Impairments | December 31, 2025 / Net Carrying Amount |
|---|---|---|---|---|---|---|
| Product brands | $22,475 | $(20,131) | $2,344 | $22,534 | $(19,981) | $2,553 |
| Corporate brands | 1,001 | (807) | 194 | 1,003 | (789) | 214 |
| Product rights/patents | 3,268 | (3,251) | 17 | 3,271 | (3,253) | 18 |
| Partner relationships, technology and other | 439 | (388) | 51 | 445 | (385) | 60 |
| Total finite-lived intangible assets | 27,183 | (24,577) | 2,606 | 27,253 | (24,408) | 2,845 |
| Acquired IPR&D | 100 | — | 100 | 100 | — | 100 |
| B&L Trademark | 1,698 | — | 1,698 | 1,698 | — | 1,698 |
| $28,981 | $(24,577) | $4,404 | $29,051 | $(24,408) | $4,643 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's finite-lived intangible assets, accumulated amortization?
- Bausch Health Companies (BHC) reported finite-lived intangible assets, accumulated amortization of $24.58B in Q1 2026.
- How has Bausch Health Companies's finite-lived intangible assets, accumulated amortization changed year-over-year?
- Bausch Health Companies's finite-lived intangible assets, accumulated amortization increased by 4.1% year-over-year, from $23.61B to $24.58B.
- What is the long-term trend for Bausch Health Companies's finite-lived intangible assets, accumulated amortization?
- Over 3 years (2022 to 2025), Bausch Health Companies's finite-lived intangible assets, accumulated amortization has grown at a 4.6% compound annual growth rate (CAGR), from $21.33B to $24.41B.
Ask your AI about Bausch Health Companies's finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude